DiaMedica Therapeutics Inc. Common Stock (DMAC) is a publicly traded Healthcare sector company. As of November 12, 2026, DMAC trades at $9.28 with a market cap of $520.92M and a P/E ratio of -12.21. DMAC moved -3.00% today. Year to date, DMAC is +9.41%; over the trailing twelve months it is +48.08%. Its 52-week range spans $3.19 to $11.00. Analyst consensus is buy with an average price target of $12.00. Rallies surfaces DMAC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks DMAC insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $9.28 |
| Market Cap | $520.92M |
| P/E Ratio | -12.21 |
| EPS | $-0.70 |
| Dividend Yield | 0.00% |
| 52-Week High | $11.00 |
| 52-Week Low | $3.19 |
| Volume | 155.69K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-32.77M |
| Gross Margin | 0.00% |
1 analysts cover DMAC: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $12.00.